Unaudited Standalone Financial Results for the half year ended on September 30, 2025 along with Limited Review Report.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Broach Lifecare Hospital reported revenue from operations of Rs 260.42 lakhs for H1 FY26 (Apr-Sep 2025), up 44% from Rs 180.84 lakhs in H1 FY25, driven by growth in healthcare services. Total expenses surged 83% to Rs 222.65 lakhs, mainly due to higher employee costs, other expenses, and purchases of stock-in-trade. Profit before tax fell 29% to Rs 41.71 lakhs, and net profit declined to Rs 31.21 lakhs (vs Rs 44.19 lakhs), translating to EPS of Rs 1.03. The company is listed on BSE SME platform (recently completed IPO) and is engaged purely in hospital/healthcare services. Auditor K.K. Haryani & Co issued a clean limited review report with no qualifications.
Strong top-line growth is a positive, but sharp expense growth has eaten into profitability, with PAT falling ~29% despite revenue rising 44%. Margin compression is a concern for shareholders, though the business remains profitable. Negative operating cash flow of Rs 157 lakhs is a watchpoint.